1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page states applications are accepted year-round; submit at least six weeks before the activity start date.
Corporate Giving in Latin America & the Caribbean is sponsored by Gilead Sciences. Gilead Sciences supports organizations working to improve access to healthcare, reduce disparities for disadvantaged groups, advance education among patients and healthcare professionals, and support local communities in Latin America and the Caribbean, including Brazil. Funding priority is given to projects addressing HIV and liver diseases.
While not directly integrative health, some initiatives could overlap with holistic patient care or educational approaches.
Get alerted about grants like this
Save a search for “Gilead Sciences” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Gilead Sciences: Corporate Giving in Latin America & the Caribbean Giving in Latin America & the Caribbean Giving in Latin America the Caribbean We work with patient advocates, nonprofits and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement.
Latin America & the Caribbean For years, Gilead has worked with local partners to provide our medicines throughout Latin America and the Caribbean. Our efforts focus on addressing unmet medical needs in the region, bringing innovative treatments to communities in Argentina, Belize, Brazil, Haiti, Jamaica and beyond.
Following our mission to create a healthier world for all people, we identify and support organizations that seek to: Improve access to healthcare Reduce disparities for disadvantaged groups Advance education among patients and healthcare professionals Support local communities In Latin America and the Caribbean, funding priority is given to projects that address HIV and liver diseases. St.
Vincent & The Grenadines We’re committed to ending the HIV epidemic in Latin America and the Caribbean. Numerous factors are driving the epidemic in this region. The social stigma of HIV-positive status leads many to decline treatment or travel great distances to be treated outside their community.
Elsewhere, poor treatment options for incarcerated populations (a group that faces systemic barriers to receiving quality HIV care) leads to public health concerns as individuals complete their rehabilitation programs and re-enter society. We support organizations working to help individuals learn their HIV status and get the care they need.
We also fund local groups looking to meet the unique needs of the region, including: Increasing awareness and understanding of HIV incidence and treatment methods Facilitating medicine provision and local provider expertise Supporting linkage to care programs Identifying and fostering prevention programs for at-risk individuals, including via pre-exposure prophylaxis (PrEP) In Latin America and the Caribbean, many people are living with undiagnosed hepatitis C, driven in part by a lack of disease awareness and diagnosis options have contributed to the persistence of this gap.
Our grantee partners seek to increase awareness of risk factors and the educational tools available to patient communities throughout the region. We also fund projects to improve diagnostics and build medical specialization in hepatitis B (HBV) and HCV.
We are working to improve the overall continuum of care for liver diseases by funding organizations that: Ensure providers have the training and expertise they need to deliver proper care Improve infrastructure and screening ability of regions where care is dependent on viral load Reduce undiagnosed totals Increase awareness of risk factors 1.
Review Our Guidelines to Ensure Your Project Is Eligible Before applying, carefully review Apply for Funding , Terms and Conditions and FAQs . If you are looking for other types of funding, see also Medical Education and Research Funding Programs . 2.
Ensure You Have a Valid Nonprofit Legal Registration You are required to be a nonprofit organization in order to be considered for funding. Proof of your status is required prior to submitting an application. You will submit your grant application via our secure online system .
4.
Complete the Online Application Be prepared to submit the following information to the online application: Dates and locations of project events (please note that grant funding is not provided for more than one year at a time and is not provided for events or programs that have already occurred) Final event agenda (please do not include the names or affiliations of presenting speakers) Target audience and publicity plan Detailed project budget, including a breakdown of how you will use the funds requested from Gilead, as well as total estimated project expenses Note: The portal offers the option to save an uncompleted draft and return to it at another time.
5. Review and Finalize Your Application Please review your application carefully before submitting it, as changes cannot be made after submission. We will send you a confirmation email after receiving your application.
We accept grant applications year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review. We will email the contact listed on your grant account profile with notification of the funding decision.
Access How to Apply for Funding With All Countries
Based on current listing details, eligibility includes: Organizations working in eligible countries (including Brazil) that align with Gilead's funding priorities of improving access to healthcare, reducing disparities, advancing education, and supporting local communities, with a focus on HIV and liver diseases. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
The Research Scholars Program in HIV, offered by Gilead Sciences, supports emerging junior faculty investigators conducting HIV-related research. Since 2008, the program has invested over $36 million in more than 300 scholars. Each cycle awards six two-year grants of $90,000 each, totaling $180,000 per scholar. Eligible applicants are junior faculty at early career stages seeking to establish independent research programs in HIV prevention, treatment, or related biomedical sciences. The next deadline is June 25, 2026. This program is ideal for academic researchers looking to build a foundation in HIV science with the backing of a major pharmaceutical funder.
HIV Research Grants (US) is sponsored by Gilead Sciences. The Gilead Research Scholars Program supports innovative research from emerging investigators globally, focusing on HIV. The program aims to incorporate new perspectives to advance scientific understanding and address unmet medical needs. It provides financial support to institutions for junior faculty researchers for a 2-year period.